Zhipeng Wang

Title: Zhipeng Wang: Innovator in Breast Cancer Therapy Prediction

Introduction

Zhipeng Wang is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical technology, particularly in cancer treatment. His work focuses on improving the prediction of patient responses to specific therapies, which can lead to more personalized and effective treatment plans.

Latest Patents

Zhipeng Wang holds a patent for a method that predicts the response to trastuzumab therapy in breast cancer patients. This invention involves a composition and method that utilizes polynucleotides to assess the likelihood of a patient's positive response to the therapy. The patent specifically details the use of nucleotide sequences and their derivatives to evaluate Her2 protein expression levels, which serve as indicators for treatment efficacy. He has 1 patent related to this innovative approach.

Career Highlights

Throughout his career, Zhipeng Wang has worked with prominent organizations, including Toray Industries, Inc. and Kyoto University. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in cancer treatment methodologies.

Collaborations

Zhipeng Wang has collaborated with esteemed colleagues such as Akira Myomoto and Satoko Kozono. These partnerships have fostered a collaborative environment that enhances research and innovation in the medical field.

Conclusion

Zhipeng Wang's contributions to predicting responses to trastuzumab therapy represent a significant advancement in breast cancer treatment. His innovative methods and collaborations continue to influence the medical community positively.